No special treatment of the disease clinical patients with different manifestations and course of using different measures to slow down the progression of the protection of renal function
In accordance with the clinical classification of IgA nephropathy
Isolated microscopic hematuria type: no special treatment, regular follow-up
Recurrent gross hematuria type: debridement and the use of triple therapy based on the number of proteinuria, such as tonsillectomy
Urinalysis abnormal type: triple therapy (wilfordii multi-glycosides of emodin of ACEI / ARB)
Vasculitis type:
) MMF regimens: methylprednisolone intravenous pulse therapy (g / d), three days after the following to prednisone mg / (KGD) mg / d to mg / d per week to reduce the maintenance of this dose of MMF g / d dosing based on blood concentrations increase to ~ g / d continuous months of ~ g, the daily dose to maintain the total course of treatment
) Cyclophosphamide (CTX) regimens: methylprednisolone impact of MMF therapy program CTX ~ g / m monthly total months after the month times the total dose <gCTX the end of treatment with azathioprine to maintain the total course of treatment
Massive proteinuria type (combined with small lesions): prednisone formal treatment
Massive proteinuria type: wilfordii multi-glycosides mg / d emodin ACEI / ARB low-protein diet
Type of hypertension: control of blood pressure / mmHgACEI / ARBCCB diuretics proteinuria> g / cases home Tripterygium glycosides piece
Other: Avoid cold tired and renal toxicity of Chinese and Western medicine and regular follow up study of attention to the respiratory tract infection prevention and control patients with recurrent tonsillitis, tonsillectomy can help mitigate the attack of hematuria and proteinuria on renal function may have long-term protection effect
|
|
Treatment of IgA nephropathy |
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
|
|
.
